<unk>  is a sulfonylurea and hypoglicemic agent that is FDA approved for the treatment of hyperglicemia in patients with non-insulin-dependent diabetes mellitus (type II) whose hyperglycemia cannot be controlled by diet alone.   Common adverse reactions include hypoglycemia, epigastric fullness, heartburn, nausea.
Tolbutamide
Arbutin
Arbutamine
Trimebutine
Glyburide
Talbutal
Phenformin
Ceftibuten